ginsenoside rh2 has been researched along with Adenocarcinoma Of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SH; Hwang, HJ; Moon, HS; Park, SY; Yoon, YE | 1 |
1 other study(ies) available for ginsenoside rh2 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cell Cycle Checkpoints; Ginsenosides; Humans; Kidney Neoplasms; Sunitinib | 2022 |